187 related articles for article (PubMed ID: 37522491)
1. The effect of secukinumab treatment for psoriasis on serum cytokines and correlation with disease severity.
Wu LT; Qiao ZH; Tian JB; Lin JL; Hou SC; Liu XM
Skin Res Technol; 2023 Jul; 29(7):e13405. PubMed ID: 37522491
[TBL] [Abstract][Full Text] [Related]
2. Alteration of serum thymus and activation-regulated chemokine level during biologic therapy for psoriasis: Possibility as a marker reflecting favorable response to anti-interleukin-17A agents.
Shibuya T; Honma M; Iinuma S; Iwasaki T; Takahashi H; Ishida-Yamamoto A
J Dermatol; 2018 Jun; 45(6):710-714. PubMed ID: 29655215
[TBL] [Abstract][Full Text] [Related]
3. Serum cytokines and growth factor levels in Japanese patients with psoriasis.
Takahashi H; Tsuji H; Hashimoto Y; Ishida-Yamamoto A; Iizuka H
Clin Exp Dermatol; 2010 Aug; 35(6):645-9. PubMed ID: 19843085
[TBL] [Abstract][Full Text] [Related]
4. Cytokine Profiles and the Relationship of Disease Severity in Patients with Psoriasis.
Wang Q; Yan D; Zheng S; Li M; Li J; Fu X; Fu D; Hu H; Song X; Tian Z
Indian J Dermatol; 2022; 67(2):204. PubMed ID: 36092198
[TBL] [Abstract][Full Text] [Related]
5. Effects of secukinumab combined with tretinoin on metabolism, liver enzymes, and inflammatory factors in patients with moderate to severe psoriasis vulgaris.
Chen Y; Yi M; Pang X; Du M; Chen H; Li Z
Postepy Dermatol Alergol; 2024 Feb; 41(1):113-120. PubMed ID: 38533361
[TBL] [Abstract][Full Text] [Related]
6. Serum profiles of pro-inflammatory and anti-inflammatory cytokines in non-hospitalized patients with mild/moderate COVID-19 infection.
Majeed AY; Zulkafli NES; Ad'hiah AH
Immunol Lett; 2023 Aug; 260():24-34. PubMed ID: 37339685
[TBL] [Abstract][Full Text] [Related]
7. IL-4, but not IL-13, modulates TARC (thymus and activation-regulated chemokine)/CCL17 and IP-10 (interferon-induced protein of 10kDA)/CXCL10 release by TNF-alpha and IFN-gamma in HaCaT cell line.
Kakinuma T; Nakamura K; Wakugawa M; Yano S; Saeki H; Torii H; Komine M; Asahina A; Tamaki K
Cytokine; 2002 Oct; 20(1):1-6. PubMed ID: 12441140
[TBL] [Abstract][Full Text] [Related]
8. IL-1β, IL-17A and combined phototherapy predicts higher while previous systemic biologic treatment predicts lower treatment response to etanercept in psoriasis patients.
Liu Y; Qin G; Meng Z; Du T; Wang X; Tang Y; Cao J
Inflammopharmacology; 2019 Feb; 27(1):57-66. PubMed ID: 30242748
[TBL] [Abstract][Full Text] [Related]
9. The effects of Malassezia in the activation of Interleukin (IL)-23/IL-17 axis in Psoriasis.
Fang H; Hou Y; Zhuang H; Wang C
New Microbiol; 2022 Apr; 45(2):130-137. PubMed ID: 35699562
[TBL] [Abstract][Full Text] [Related]
10. Dynamic changes of Th1/Th2/Th17 cytokines and hBD-2/3 in erosive oral lichen planus patients saliva before and after prednisone acetate treatment.
Jiang L; Huang Y; Fang M; Chen X; Feng D; Liu J; Jiang Q; Tao R
Heliyon; 2024 Jan; 10(1):e24043. PubMed ID: 38283247
[TBL] [Abstract][Full Text] [Related]
11. β-Defensin 2 is a responsive biomarker of IL-17A-driven skin pathology in patients with psoriasis.
Kolbinger F; Loesche C; Valentin MA; Jiang X; Cheng Y; Jarvis P; Peters T; Calonder C; Bruin G; Polus F; Aigner B; Lee DM; Bodenlenz M; Sinner F; Pieber TR; Patel DD
J Allergy Clin Immunol; 2017 Mar; 139(3):923-932.e8. PubMed ID: 27502297
[TBL] [Abstract][Full Text] [Related]
12. Correlations between skin lesions induced by anti-tumor necrosis factor-α and selected cytokines in Crohn's disease patients.
Włodarczyk M; Sobolewska A; Wójcik B; Loga K; Fichna J; Wiśniewska-Jarosińska M
World J Gastroenterol; 2014 Jun; 20(22):7019-26. PubMed ID: 24944497
[TBL] [Abstract][Full Text] [Related]
13. [Research on different expressions of peripheral blood Th1/Th2 cells in psoriasis patients of blood heat syndrome and of blood stasis syndrome].
Chen J; Cao XX; Xu R; Li X; Li FL; Fan B; Wang YF; Li F; Li B
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Jan; 34(1):46-50. PubMed ID: 24520787
[TBL] [Abstract][Full Text] [Related]
14. Skin IL-17A and IFN-γ Production Correlate with Disease Severity in Patients with Psoriasis and Streptococcal Infection.
Della Bella C; Corrà A; Mantengoli E; Galano A; Benagiano M; Bonciani D; Mariotti EB; Pratesi S; Quintarelli L; Aimo C; Grassi A; D'Elios S; Volpi W; Verdelli A; Bartoloni A; Rossolini GM; D'Elios MM; Caproni M
J Invest Dermatol; 2023 Jun; 143(6):925-932. PubMed ID: 36642401
[TBL] [Abstract][Full Text] [Related]
15. Secukinumab for patients failing previous tumour necrosis factor-α inhibitor therapy: results of a randomized open-label study (SIGNATURE).
Warren RB; Barker JNWB; Finlay AY; Burden AD; Kirby B; Armendariz Y; Williams R; Hatchard C; Khare S; Griffiths CEM
Br J Dermatol; 2020 Jul; 183(1):60-70. PubMed ID: 31628677
[TBL] [Abstract][Full Text] [Related]
16. Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment.
Tillack C; Ehmann LM; Friedrich M; Laubender RP; Papay P; Vogelsang H; Stallhofer J; Beigel F; Bedynek A; Wetzke M; Maier H; Koburger M; Wagner J; Glas J; Diegelmann J; Koglin S; Dombrowski Y; Schauber J; Wollenberg A; Brand S
Gut; 2014 Apr; 63(4):567-77. PubMed ID: 23468464
[TBL] [Abstract][Full Text] [Related]
17. Immune Regulation of TNFAIP3 in Psoriasis through Its Association with Th1 and Th17 Cell Differentiation and p38 Activation.
Jiang Y; Wang W; Zheng X; Jin H
J Immunol Res; 2020; 2020():5980190. PubMed ID: 32280718
[TBL] [Abstract][Full Text] [Related]
18. TNF-α inhibitors reduce the pathological Th
Campanati A; Orciani M; Lazzarini R; Ganzetti G; Consales V; Sorgentoni G; Di Primio R; Offidani A
Exp Dermatol; 2017 Apr; 26(4):319-324. PubMed ID: 27376466
[TBL] [Abstract][Full Text] [Related]
19. A novel role of IL-17A in contributing to the impaired suppressive function of Tregs in psoriasis.
Liu Y; Zhang C; Li B; Yu C; Bai X; Xiao C; Wang L; Dang E; Yang L; Wang G
J Dermatol Sci; 2021 Feb; 101(2):84-92. PubMed ID: 33334656
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Th1 and Th17 Inflammatory Cytokine Profiles Between Chronic Plaque and Acute Guttate Psoriasis.
Ju HJ; Park HJ; Choi IH; Lee KH; Kwon MY; Park CJ
Ann Dermatol; 2022 Jun; 34(3):200-205. PubMed ID: 35721337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
